A small, Californian biotechnology company reported on Tuesday that an experimental medicine it's been developing for a form of bone marrow cancer succeeded in a late-stage clinical trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,